Quantcast
Last updated on April 21, 2014 at 8:55 EDT

Latest Systems biology Stories

2014-04-13 23:00:56

Metabolomics is one of the fastest growing markets in the scientific arena, finding its application in essential fields such as drug discovery, toxicology assessment, nutrigenomics and biomarker discovery. http://www.marketsandmarkets.com/Market-Reports/metabolomics-technology-market-900.html (PRWEB) April 13, 2014 The report "Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and...

Bacterial ‘FM Radio’ Developed By Researchers
2014-04-10 13:46:36

By Kim McDonald, UC San Diego Programming living cells offers the prospect of harnessing sophisticated biological machinery for transformative applications in energy, agriculture, water remediation and medicine.  Inspired by engineering, researchers in the emerging field of synthetic biology have designed a tool box of small genetic components that act as intracellular switches, logic gates, counters and oscillators. But scientists have found it difficult to wire the components...

2014-04-08 12:22:32

ALBANY, New York, April 8, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Synthetic Biology Market (Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA, Chassis Organisms, DNA Synthesis, Oligonucleotide Synthesis)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2013 - 2019" the global synthetic biologymarket was valued at USD 1.8 billion in 2012 and is estimated to reach a market worth of USD 13.4 billion...

2014-04-07 11:14:25

UH Math collaborates with Rice on synthetic gene circuit A long-standing challenge in synthetic biology has been to create gene circuits that behave in predictable and robust ways. Mathematical modeling experts from the University of Houston (UH) collaborated with experimental biologists at Rice University to create a synthetic genetic clock that keeps accurate time across a range of temperatures. The findings were published in a recent issue of the Proceedings of the National Academy of...

2014-03-21 08:23:43

INNSBRUCK, Austria, March 21, 2014 /PRNewswire/ -- - A US research team has developed the world's first blood test capable of predicting, with 90% accuracy, the risk of Alzheimer's disease 2-3 years in advance. The findings, published in Nature Medicine, were generated using the AbsoluteIDQ(R) p180 test kit by Austrian BIOCRATES Life Sciences AG. A team of US researchers has developed the world's first blood test capable of predicting Alzheimer's. The...

2014-03-13 16:28:42

DUBLIN, March 13, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/9q57nq/global) have announced the addition of the "Global Bioinformatics Market Outlook 2018" [http://www.researchandmarkets.com/research/9q57nq/global ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Bioinformatics is at the forefront of biotechnology revolution. Over the past decade, the bioinformatics market has...

2014-03-12 08:30:52

Former Endo Health and Johnson & Johnson Executive to Join as Senior Vice President GERMANTOWN, Md., March 12, 2014 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the appointment of Kelly Huang, Ph.D., most recently President of HealthTronics, Inc., a subsidiary of Endo Health Solutions, to head the Company's newly established Consumer Sector. Dr. Huang will join Intrexon effective March 17, reporting to Chairman and Chief Executive...

2014-02-26 08:30:03

Single Largest Prospective Pan-Omic Study Will Investigate Blood-Based Protein Markers of Disease RICHMOND, Va. and MONTREAL, Feb. 26, 2014 /PRNewswire/ -- Global Genomics Group (G3) and Caprion Proteomics, Inc., today announced that they have entered into a collaboration agreement to investigate biological networks and pathways in order to discover novel biomarkers and pharmaceutical targets for cardiovascular diseases. Under the terms of the agreement, Caprion will identify...

2014-02-13 08:31:56

Pilot Data of Single Largest Prospective Pan-Omic Study to Identify Key Biomarkers and Central Therapeutic Targets for Cardiovascular Diseases Expected Later This Year RICHMOND, Va., Feb. 13, 2014 /PRNewswire/ -- Global Genomics Group (G3) today announced that it has completed enrollment of the 5,000-patient discovery cohort of its GLOBAL (Genetic LOci and Burden of Atherosclerotic Lesions) clinical study. Pilot data for the first cohort of patients are expected later this year....

2014-02-12 04:20:52

MARCO ISLAND, Florida and HILDEN, Germany, February 12, 2014 /PRNewswire/ -- - Significant expansion of 'universal' portfolio compatible with any NGS system includes several novel sample preparation products as well as solutions for clinical use - New bioinformatics solutions, including CLC Cancer Research Workbench and Ingenuity Clinical will accelerate analysis and interpretation of NGS data QIAGEN N.V. (NASDAQ:...